Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 2:15 pm Sale |
2025-03-31 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 10,931,257 5.500% |
-4,232,629 (-27.91%) |
Filing History |
| 2025-03-10 11:12 am Sale |
2025-03-04 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 9,694,064 4.900% |
-250,000 (-2.51%) |
Filing History |
| 2025-02-14 2:37 pm Purchase |
2024-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 9,944,064 5.000% |
750,000 (+8.16%) |
Filing History |
| 2024-11-14 08:42 am Sale |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
Two Seas Capital LP | 6,584,278 3.300% |
-1,101,842 (-14.34%) |
Filing History |
| 2024-11-12 2:23 pm Unchanged |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 13,043,077 6.640% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
BLACKROCK INC BLK |
14,265,367 7.300% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:33 pm Unchanged |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 13,043,077 6.640% |
0 (Unchanged) |
Filing History |
| 2024-11-04 12:09 pm Purchase |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 13,043,077 6.640% |
7,905,327 (+153.87%) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
BLACKROCK INC BLK |
14,265,367 7.300% |
9,620,008 (+207.09%) |
Filing History |
| 2024-10-17 4:34 pm Sale |
2024-09-30 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 3,403,530 1.700% |
-6,772,999 (-66.56%) |
Filing History |
| 2024-06-12 4:26 pm Purchase |
2024-06-10 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 10,176,529 5.400% |
6,532,578 (+179.27%) |
Filing History |
| 2024-02-14 2:14 pm Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
CVI Investments, Inc. | 0 0.000% |
-5,500,000 (Position Closed) |
Filing History |
| 2024-02-14 10:50 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Two Seas Capital LP | 7,686,120 6.800% |
-236,050 (-2.98%) |
Filing History |
| 2024-02-14 08:42 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Deep Track Capital, LP | 0 0.000% |
-6,345,790 (Position Closed) |
Filing History |
| 2024-02-14 06:11 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 209,971 0.200% |
-4,323,785 (-95.37%) |
Filing History |
| 2024-02-13 5:04 pm Purchase |
2023-12-29 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 5,137,750 4.520% |
877,286 (+20.59%) |
Filing History |
| 2024-02-09 4:14 pm Purchase |
2024-02-09 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 15,163,886 12.600% |
5,362,725 (+54.72%) |
Filing History |
| 2024-01-24 3:46 pm Purchase |
2024-01-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 9,194,064 5.100% |
5,000,000 (+119.22%) |
Filing History |
| 2024-01-24 3:21 pm Unchanged |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,194,064 3.700% |
0 (Unchanged) |
Filing History |
| 2024-01-17 5:01 pm Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
MILLENNIUM MANAGEMENT LLC | 3,643,951 3.200% |
-1,722,501 (-32.10%) |
Filing History |